Wutah pendapatan taun lumaku: Kronos Bio Corporation (KRON)

Logo perusahaan publik kronosbio.com (KRON)

Kronos Bio, Inc. (KRON) develops targeted therapies against tumor factors, relying on reimbursements from insurance systems and medical centers. Year-over-year sales growth (TTM) illustrates the impact of patent protection and FDA approvals, where the value 0.00 describes the current level. The company is currently expanding its precision medicine portfolio, researching complex oncogenic pathways to combat hard-to-treat forms of cancer.

Kronos Bio, Inc. (KRON): Wutah pendapatan YoY sajrone 12 wulan kepungkur saka 11.02.2024 nganti 20.02.2024

Kronos Bio, Inc. - rincian analitis lan metrik utama (KRON)

- rega saham lan target rega konsensus:
- indikator kapitalisasi bursa perusahaan:
Ringkesan analitik perusahaan:Kronos Bio Corp
Produk merek Kronos Bio Corporation

Kronos Bio, Inc. (KRON) maintains a strong academic position within the oncology sector, although its capital management efficiency requires strict monitoring. By analyzing the historical year-over-year revenue growth trend over the last 12 months, an investor can filter out market noise and determine whether growth is driven by real business expansion or merely inflationary factors, which is critical for assessing the company's cash burn rate.

Karo sapa Kronos Bio, Inc. saingan

Incyte Pharma - Wutah dodolan YoY sajrone rolas wulan kepungkur|HUTCHMED Corp - Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku Nuvation Bio Inc.|DAWN: Wutah dodolan YoY (TTM)|Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur Monopar Pharma MNPR|Wutah pendapatan YoY sajrone 12 wulan kepungkur INBX|Wutah pendapatan taun lumaku I-Mab Biopharma IMAB|Wutah pendapatan YoY sajrone 12 wulan kepungkur FENC (Fennec Pharmaceuticals)|HRTX (Heron Therapeutics Inc) - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Nuvectis Pharma, Inc. - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur CHRS (Coherus BioSciences)|Corbus Pharma - Wutah dodolan YoY (TTM)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur CRDF (cardiffoncology.com)|BYSI: Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku BioAtla Corp (BCAB)|Wutah dodolan YoY sajrone rolas wulan kepungkur Lixte Biotechnology Holdings, Inc.|CTXR: Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY (TTM) CLRB|Wutah dodolan YoY (TTM) BioLineRx Corporation (BLRX)|Wutah dodolan YoY sajrone rolas wulan kepungkur Can-Fite BioPharma, Ltd. CANF|APRE (aprea.com) - Wutah dodolan taun lumaku|KZIA: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taun lumaku Silexion Therapeutics|NuCana plc (NCNA) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur Chimerix, Inc|Wutah pendapatan YoY sajrone 12 wulan kepungkur CYCC|Wutah pendapatan YoY sajrone 12 wulan kepungkur G1 Therapeutics (GTHX)|Wutah dodolan YoY sajrone rolas wulan kepungkur Kintara (KTRA)|Wutah pendapatan YoY sajrone 12 wulan kepungkur Oncternal ONCT|Portage Biotech - Wutah pendapatan YoY sajrone 12 wulan kepungkur